Bluu Seafood, the German-based food biotech startup, has raised EUR 16 million in Series A Funding to launch its cultivated fish products in Singapore next year.
The company will initially concentrate on obtaining regulatory approval for its first products including fish balls and fish fingers made from cultivated fish cells as well as expanding the research work on its groundbreaking technology.
After the approval of its cultivated chicken products in 2020, Bluu Seafood aims to enter the Singapore market with its Bluu’s cultivated fish by the end of next year.
Sebastian Rakers, co-founder and CEO of Bluu Seafood, explained that there is an enormous future potential that lies in cultivated fish as a platform technology for sustainable animal protein.
“Our highly successful Series-A underlines the strong scientific development that Bluu Seafood and our excellent team have delivered so far,” added Rakers.
“Together with our strong, international investor base, we can start the next stage of development and bring our first products to market.”
Currently, the company has scaled up its pilot production plant into larger fermenters that can hold up to 500 litres.
Additionally, Bluu Seafood has requested the approval from FDA to introduce its cultivated seafood products to the US market.
- Recommended reading: Magic Valley launches cultivated pork made without harming animals.
